Abstract:Background: Multi-omics investigation can help shed light on the complex mechanisms underlying Major Depressive Disorder (MDD). However, the integrated genetic changes in brain structure among individual patients are not yet understood. In this study, we combined DNA methylation and gene expression data to better understand the neurobiological basis of gray matter deficits in MDD.Methods: We recruited 269 patients and 416 healthy controls (HC) and collected T1-weighted images and peripheral DNA methylation microarrays. We examined differences in gray matter volume (GMV) between groups and identified GMV changes related gene expression using imaging transcriptomic analysis. We selected differentially methylated CpG positions (DMPs) and investigated the association between DMPs and GMV in patients. Then we also examined the correlation between DNA methylation and gene expression.Findings: We found significantly decreased GMV in anterior cingulate cortex (ACC), dorsolateral prefrontal cortex, inferior frontal cortex (IFG), fusiform face cortex (FFC) in MDD. The changes in GMV were associated with genes involved in neurodevelopment, neurotransmitter regulation, and metabolism. Additionally, we found that multiple DMPs in genes of these biological processes were significantly correlated with GMV changes in the IFG, ACC and FFC across individual patients. We also found a significant negative correlation between DNA methylation and gene expression in IFG. Interpretation: Our results suggest that variations in gray matter structure in MDD may be transcriptionally and epigenetically regulated. These findings indicate that epigenetic changes in blood that are associated with brain structural deficits may serve as potential predictive biomarkers for MDD patients.Funding: This study was supported by grants from National Science Fund for Distinguished Young Scholars (81725005), NSFC-Guangdong Joint Fund (U20A6005), National Natural Science Foundation of China (62176129) and China Postdoctoral Science Foundation (2022M721681).Declaration of Interest: The authors declare no competing interests.Ethical Approval: The participants over 18 year old signed a written consent form themselves. If the participants age were less than 18 years, their parental/legal guardian provided written informed consent. This study was approved by the Ethics Committee of the first affiliated Hospital of China Medical University.

Transcriptomic Similarity Informs Neuromorphic Deviations in Depression Biotypes.

Biotypes of major depressive disorder: Neuroimaging evidence from resting-state default mode network patterns.

Identifying Subgroups of Major Depressive Disorder Using Brain Structural Covariance Networks and Mapping of Associated Clinical and Cognitive Variables

Transcriptional and Cellular Signatures of Morphometric Similarity Remodeling in Major Depressive Disorder

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

Brain connectivity and transcriptomic similarity inform abnormal morphometric similarity patterns in first-episode, treatment-naïve major depressive disorder

A Joint Study of Whole Exome Sequencing and Structural MRI Analysis in Major Depressive Disorder.

Cortical Structural Differences in Major Depressive Disorder Correlate with Cell Type-Specific Transcriptional Signatures

White Matter Abnormalities in Major Depression Biotypes Identified by Diffusion Tensor Imaging.

Dissecting Biological Heterogeneity in Major Depressive Disorder Based on Neuroimaging Subtypes with Multi-Omics Data

Biotypes of Major Depressive Disorder Identified by a Multiview Clustering Framework

Characterizing the distinct imaging phenotypes, clinical behavior, and genetic vulnerability of brain maturational subtypes in mood disorders

Integrative omics analysis reveals epigenomic and transcriptomic signatures underlying brain structural deficits in major depressive disorder

Identifying two distinct neuroanatomical subtypes of first-episode depression using heterogeneity through discriminative analysis

Spatial Expression Pattern of ZNF391 Gene in the Brains of Patients with Schizophrenia, Bipolar Disorders or Major Depressive Disorder Identifies New Cross-Disorder Biotypes: A Trans-Diagnostic, Top-Down Approach

Gene Expression Analysis of Multiple Brain Regions in Major Depressive Disorder

Transcriptomic pathology of neocortical microcircuit cell types across psychiatric disorders

Neurophysiological Stratification of Major Depressive Disorder by Distinct Trajectories

Data-driven Clustering Differentiates Subtypes of Major Depressive Disorder with Distinct Brain Connectivity and Symptom Features

Multi-Omics Integration Reveals Transcriptomic and Epigenetic Signatures Underlying Brain Structural Deficits in Major Depressive Disorder

Transcriptomic decoding of regional cortical vulnerability to major depressive disorder